These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 7366519)
1. [Dose-response comparison with etiroxat HCl in hyperlipoproteinemias types IIa and IIb]. Banz H; Gall FP Med Klin; 1980 Jan; 75(1):35-6. PubMed ID: 7366519 [No Abstract] [Full Text] [Related]
2. [Therapy of hyperlipoproteinemia type IIa and IIb with etiroxate-HCl. Dose-response comparison]. Banz H; Gall FP Fortschr Med; 1979 Nov; 97(42):1942-1947. PubMed ID: 520990 [TBL] [Abstract][Full Text] [Related]
3. [Etiroxate treatment for hyperlipoproteinaemia type IIa and IIb (author's transl)]. Zadák Z; Kalinová M; Sobotka L Cas Lek Cesk; 1982 May; 121(19):593-5. PubMed ID: 7093991 [No Abstract] [Full Text] [Related]
4. Comparison of therapy with simvastatin 80 mg and 120 mg in patients with familial hypercholesterolaemia. Wierzbicki AS; Lumb PJ; Chik G Int J Clin Pract; 2001 Dec; 55(10):673-5. PubMed ID: 11777291 [TBL] [Abstract][Full Text] [Related]
5. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study. Domingo AJ; Gutiérrez JA; Menéndez JA; Micó L; Muñoz M; de Oya M Clin Ther; 1980; 3(3):219-26. PubMed ID: 7459931 [TBL] [Abstract][Full Text] [Related]
6. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types]. Noseda G; Fragiacomo C; Weidmann P; Bachmann C Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660 [TBL] [Abstract][Full Text] [Related]
7. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia. Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099 [TBL] [Abstract][Full Text] [Related]
8. Enhanced hype. Harrison DG; Brown WV; Raggi P Am J Cardiol; 2008 Aug; 102(3):368-9. PubMed ID: 18638604 [TBL] [Abstract][Full Text] [Related]
9. Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs. Hutt V; Wechsler JG; Klör HU; Ditschuneit H Artery; 1980; 8(2):113-9. PubMed ID: 7458676 [TBL] [Abstract][Full Text] [Related]
10. [Lowering of LDL cholesterol prevents cardiovascular diseases. "Normal values" are too high--treatment time is a crucial factor]. Rudling M Lakartidningen; 2006 Oct 25-31; 103(43):3278-82. PubMed ID: 17117659 [No Abstract] [Full Text] [Related]
11. [Familial hypercholesterolemia]. Heinzl S Med Monatsschr Pharm; 1987 Dec; 10(12):381-7. PubMed ID: 3325786 [No Abstract] [Full Text] [Related]
12. [After several years of statin therapy. Long-term prevention of cardiac death]. MMW Fortschr Med; 2003 Feb; 145(8):56. PubMed ID: 12661448 [No Abstract] [Full Text] [Related]
13. [Cholesterol--now what?]. Smith P Tidsskr Nor Laegeforen; 2001 Mar; 121(9):1022. PubMed ID: 11354872 [No Abstract] [Full Text] [Related]
14. [Polyphepan (lignin) as an hypocholesteremic agent]. Frolkis AV; Abramzon MA; Kislova GD; Levanova VP Klin Med (Mosk); 1987 Jul; 65(7):48-52. PubMed ID: 3312799 [No Abstract] [Full Text] [Related]
15. [Therapy of hyperlipoproteinemia type IIa, IIb and IV with Etofibrate retard]. Schwartzkopff W; Schilling A; Calder D Med Welt; 1980 Apr; 31(14):515-20. PubMed ID: 7374415 [No Abstract] [Full Text] [Related]
16. ENHANCE: food for the ostriches. Jackson G Int J Clin Pract; 2008 May; 62(5):667-8. PubMed ID: 18412925 [No Abstract] [Full Text] [Related]
17. Simvastatin with or without ezetimibe in familial hypercholesterolemia. Kaye T N Engl J Med; 2008 Jul; 359(5):531-2; author reply 532-3. PubMed ID: 18677800 [No Abstract] [Full Text] [Related]
18. [Should children with familial hypercholesterolemia be treated with statins?]. Tonstad S Lakartidningen; 2004 Oct; 101(44):3406. PubMed ID: 15560654 [No Abstract] [Full Text] [Related]
19. [Approved indication for Ezetrol]. Eriksson N; Phillipson T Lakartidningen; 2005 Mar 14-20; 102(11):887. PubMed ID: 15835530 [No Abstract] [Full Text] [Related]